Advertisement
Screener

RIGEL PHARMACEUTICALS, INC. (RIGL) Other

RIGEL PHARMACEUTICALS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-03: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · RIGL · NASDAQ.
  • 2025-03-04: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · RIGL · NASDAQ.
  • 2024-03-05: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · RIGL · NASDAQ.
  • 2023-03-07: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $.001 per share · RIGL · NASDAQ.
FiledFormItemAs filed
2026-03-0310-KStock registered under Section 12(b)Common Stock, par value $.001 per share · RIGL · NASDAQ
2025-03-0410-KStock registered under Section 12(b)Common Stock, par value $.001 per share · RIGL · NASDAQ
2024-03-0510-KStock registered under Section 12(b)Common Stock, par value $.001 per share · RIGL · NASDAQ
2023-03-0710-KStock registered under Section 12(b)Common Stock, par value $.001 per share · RIGL · NASDAQ
2022-03-0110-KStock registered under Section 12(b)Common Stock, par value $.001 per share · RIGL · NASDAQ
2021-11-0210-QSmaller reporting companyYes
2021-08-0310-QSmaller reporting companyYes
2021-05-0510-QSmaller reporting companyYes
2021-03-0210-KStock registered under Section 12(b)Common Stock, par value $.001 per share · RIGL · NASDAQ
2021-03-0210-KSmaller reporting companyYes
2020-11-0510-QSmaller reporting companyYes
2020-08-0410-QSmaller reporting companyYes
2020-05-0510-QSmaller reporting companyYes
2020-02-2710-KSmaller reporting companyYes
2019-11-0510-QSmaller reporting companyYes
2019-08-0610-QSmaller reporting companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Apnimed, Inc. (APMD)United States$0.899B
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Cryoport, Inc. (CYRX)United States$0.881B-21.29
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Arbutus Biopharma Corp (ABUS)$0.965B6.19